financetom
Business
financetom
/
Business
/
Accenture beats third-quarter revenue estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Accenture beats third-quarter revenue estimates
Jun 20, 2025 4:18 AM

(Reuters) -Accenture ( ACN ) beat Wall Street estimates for third-quarter revenue on Friday, driven by growing demand for the consulting giant's AI-driven services from enterprise customers.

It reported revenue of $17.7 billion for the quarter ended May 31, compared with analysts' average estimate of $17.30 billion, according to data compiled by LSEG.

Shares of the company fell 2.6% in premarket trading after Accenture ( ACN ) said new bookings decreased 6% to $19.7 billion in the third quarter.

The company is grappling with weak U.S. federal contracting environment as the Trump administration has slowed new contracts and cut existing agreements in a bid to reduce federal spending.

The company said these changes have not had a material impact on its operations or financial condition.

(Reporting by Meghana Khare and Jaspreet Singh in Bengaluru; Editing by Shinjini Ganguli)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Atlantic Union Bankshares to buy Sandy Spring Bancorp in $1.6 bln deal
Atlantic Union Bankshares to buy Sandy Spring Bancorp in $1.6 bln deal
Oct 21, 2024
Oct 21 (Reuters) - Regional lender Atlantic Union Bankshares ( AUB ) will buy smaller rival Sandy Spring Bancorp ( SASR ) in a $1.6 billion deal, the companies said on Monday. ...
Lilly sues online vendors, medical spa over copycat weight-loss drugs
Lilly sues online vendors, medical spa over copycat weight-loss drugs
Oct 21, 2024
Oct 21 (Reuters) - Eli Lilly LLY.N said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound, including in the form of dissolvable tablets. The new lawsuits, which name Pivotal Peptides, MangoRx and Genesis Lifestyle Medicine of Nevada, are the first related to...
Novo Nordisk's diabetes pill cuts heart risk by 14% in late-stage study
Novo Nordisk's diabetes pill cuts heart risk by 14% in late-stage study
Oct 21, 2024
Oct 21 (Reuters) - Novo Nordisk said on Monday the oral version of its drug semaglutide, Rybelsus, helped reduce risk of cardiovascular diseases in patients by 14% in a late-stage study. (Reporting by Mariam Sunny in Bengaluru; Editing by Anil D'Silva) ...
Microsoft to allow autonomous AI agent development starting next month
Microsoft to allow autonomous AI agent development starting next month
Oct 21, 2024
By Aditya Soni Oct 21 (Reuters) - Microsoft ( MSFT ) will allow customers to build autonomous artificial intelligence agents starting in November, the software giant said on Monday, in its latest move to tap the booming technology. The company is positioning autonomous agents - programs which require little human intervention unlike chatbots - as apps for an AI-driven world,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved